…b (BAR) and tofacitinib (TOF), are oral therapeutic options for rheumatoid arthritis (RA). Evaluating treatment persistence, defined as the duration…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 33 of 2459…ation, which are key mediators of IR. A study demonstrated that sinomenine protects against myocardial ischemia-reperfusion injury by prev…
… variants in the NADPH oxidase 2 (NOX2) complex associated with systemic lupus erythematosus (SLE), secondary antiphospholipid syndrome (sAPS), or Sjögren’s…
…46-022-02251-2Daubon T, Hemadou A, Romero Garmendia I, Saleh M. Glioblastoma immune landscape and the potential of new immunotherapies. Fron…
…urn may be clinically relevant in optimising disease control in asthma and COPD.…
…Introduction Bronchiolitis represents one of the most common respiratory tract infections …
…group, patients achieving a clinical complete response (cCR) to camrelizumab combined with neoCRT will undergo active surveillance, while th…
…, 94 de novo lesions treated, with 76.6% (lesions=72) receiving Paclitaxel. Mean age 66.8 years (SD 11.53); 86.5% male. Obesity (BMI >30) …
…Immunosuppression 100 (27%)• Azathioprine (38)• Budesonide (7)• Mercaptopurine (5)• Mycophenolate (40)• Prednisolone (4)• Tacrolimus (6) Prima…
…combined with two local anaesthetic adjuncts (dexamethasone and dexmedetomidine) for postoperative pain relief in VATS patients.Methods and ana…
…iven revascularisation, serious infection or diarrhoea. For the spironolactone comparison, the outcome included all-cause death, stroke, MI, n…
…verse effectsReferences Pehora C, Pearson AM, Kaushal A, et al. Dexamethasone as an adjuvant to peripheral nerve block. Cochrane Database of …